Recursion Pharmaceuticals, Inc. is advancing REC-1245, an RBM39 degrader, in the DHALIA trial in solid tumors. Read more on ...

Add Yahoo as a preferred source to see more of our stories on Google. logos of OpenAI Anadolu via Getty Images There’s interesting news coming from Sam Altman’s empire, a firm known for innovating as ...

Anthropic says AI development may need to slow as systems approach recursive self-improvement. The company proposes global ...

Anthropic warns self‑improving AI could outpace human control, urging a slowdown as risks grow and systems begin advancing on ...

Following piloted FX activity, Krytheon advances toward point-of-sale deployment across a 23-country carrier and its ...

METR, which runs the benchmark measuring how well models can complete long-duration tasks, found that Claude Mythos Preview ...

Anthropic is calling for joint efforts to slow the development of AI, using arms control agreements as a model. But that's a ...

Claude now authors 80% of Anthropic's production code. The company's new paper maps the path to recursive self-improvement and calls for a global pause mechanism.

Yuandong Tian, who spent more than a decade as a research scientist director inside Meta’s Fundamental AI Research lab, has ...